(Q47783446)

English

Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

0 references

author name string

Duffy RA

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Hedrick JA

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Randolph G

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Morgan CA

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Cohen-Williams ME

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Vassileva G

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Lachowicz JE

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Laverty M

8

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Maguire M

9

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Shan LS

10

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Gustafson E

11

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Varty GB

12

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

publication date

1 August 2003

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Neuropharmacology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

45

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

242-250

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Pharmacological profile of the novel mammalian tachykinin, hemokinin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Pharmacological profile of hemokinin 1: a novel member of the tachykinin family

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Effects of substance P and neurokinin A (substance K) on motor behavior: unique effect of substance P attributable to its amino-terminal sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Nonpeptide antagonists of the NK1 tachykinin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Hemokinin 1 is a full agonist at the substance P receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Differential ability of tachykinin NK-1 and NK-2 agonists to produce scratching and grooming behaviours in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Neurokinin(1) receptor antagonists as potential antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Tachykinin-like peptides and their receptors. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Structure-activity relationship of neurokinin A(4-10) at the human tachykinin NK(2) receptor: the effect of amino acid substitutions on receptor affinity and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900150-3

7 January 2021

Identifiers

10.1016/S0028-3908(03)00150-3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12842130

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47783446&oldid=1375894114"